Literature DB >> 26046416

Tapering Long-term Opioid Therapy in Chronic Noncancer Pain: Evidence and Recommendations for Everyday Practice.

Chantal Berna1, Ronald J Kulich2, James P Rathmell3.   

Abstract

Increasing concern about the risks and limited evidence supporting the therapeutic benefit of long-term opioid therapy for chronic noncancer pain are leading prescribers to consider discontinuing the use of opioids. In addition to overt addiction or diversion, the presence of adverse effects, diminishing analgesia, reduced function and quality of life, or the absence of progress toward functional goals can justify an attempt at weaning patients from long-term opioid therapy. However, discontinuing opioid therapy is often hindered by patients' psychiatric comorbidities and poor coping skills, as well as the lack of formal guidelines for the prescribers. The aim of this article is to review the existing literature and formulate recommendations for practitioners aiming to discontinue long-term opioid therapy. Specifically, this review aims to answer the following questions: What is an optimal opioid tapering regimen? How can the risks involved in a taper be managed? What are the alternatives to an opioid taper? A PubMed literature search was conducted using the keywords chronic pain combined with opioid withdrawal, taper, wean and detoxification. Six hundred ninety-five documents were identified and screened; 117 were deemed directly relevant and are included. On the base of this literature review, this article proposes evidence-based recommendations and expert-based suggestions for clinical practice. Furthermore, areas of lack of evidence are identified, providing opportunities for further research.
Copyright © 2015 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26046416     DOI: 10.1016/j.mayocp.2015.04.003

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  62 in total

1.  American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.

Authors:  Amanda M Brandow; C Patrick Carroll; Susan Creary; Ronisha Edwards-Elliott; Jeffrey Glassberg; Robert W Hurley; Abdullah Kutlar; Mohamed Seisa; Jennifer Stinson; John J Strouse; Fouza Yusuf; William Zempsky; Eddy Lang
Journal:  Blood Adv       Date:  2020-06-23

2.  Opioid Taper Is Associated with Subsequent Termination of Care: a Retrospective Cohort Study.

Authors:  Hector R Perez; Michele Buonora; Chinazo O Cunningham; Moonseong Heo; Joanna L Starrels
Journal:  J Gen Intern Med       Date:  2019-08-19       Impact factor: 5.128

3.  Analgesic reduction during an interdisciplinary pain management programme: treatment effects and processes of change.

Authors:  Beth J Guildford; Aisling Daly-Eichenhardt; Bethany Hill; Karen Sanderson; Lance M McCracken
Journal:  Br J Pain       Date:  2017-10-02

4.  Managing Chronic Pain in an Opioid Crisis: What Is the Role of Shared Decision-Making?

Authors:  Marianne S Matthias; Tasneem L Talib; Monica A Huffman
Journal:  Health Commun       Date:  2019-06-10

Review 5.  Common Functional Gastroenterological Disorders Associated With Abdominal Pain.

Authors:  Adil E Bharucha; Subhankar Chakraborty; Christopher D Sletten
Journal:  Mayo Clin Proc       Date:  2016-08       Impact factor: 7.616

Review 6.  Opioid Treatment of Migraine: Risk Factors and Behavioral Issues.

Authors:  Melissa T Stone; Valerie Weed; Ronald J Kulich
Journal:  Curr Pain Headache Rep       Date:  2016-09

Review 7.  Opioid Management: Initiating, Monitoring, and Tapering.

Authors:  W Michael Hooten
Journal:  Phys Med Rehabil Clin N Am       Date:  2020-03-11       Impact factor: 1.784

8.  Guidance on opioid tapering in the context of chronic pain: Evidence, practical advice and frequently asked questions.

Authors:  Laura Murphy; Roshina Babaei-Rad; Donna Buna; Pearl Isaac; Andrea Murphy; Karen Ng; Loren Regier; Naomi Steenhof; Maria Zhang; Beth Sproule
Journal:  Can Pharm J (Ott)       Date:  2018-02-08

9.  Race and Gender Are Associated with Opioid Dose Reduction Among Patients on Chronic Opioid Therapy.

Authors:  Michele Buonora; Hector R Perez; Moonseong Heo; Chinazo O Cunningham; Joanna L Starrels
Journal:  Pain Med       Date:  2019-08-01       Impact factor: 3.750

Review 10.  Optimizing Placebo and Minimizing Nocebo to Reduce Pain, Catastrophizing, and Opioid Use: A Review of the Science and an Evidence-Informed Clinical Toolkit.

Authors:  Beth D Darnall; Luana Colloca
Journal:  Int Rev Neurobiol       Date:  2018-08-06       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.